ArticleAnnals of medicine and surgery (2012)2026
Advancing hypoparathyroidism treatment: FDA approval of Palopegteriparatide as a promising orphan drug.
Syeda Rabiah Shahid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it